The relationship between non‐injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use
- 14 June 2005
- Vol. 100 (7) , 990-1002
- https://doi.org/10.1111/j.1360-0443.2005.01098.x
Abstract
Aims To evaluate the effects of longitudinal patterns and types of non‐injection drug use (NIDU) on HIV progression in the highly active antiretroviral therapy (HAART) era.Design Women's Interagency HIV Study (WIHS), a prospective cohort study conducted at six US sites.Methods Data were collected semi‐annually from 1994 to 2002 on 1046 HIV+ women. Multivariate Cox proportional hazards modeling was used to estimate relative hazards for developing AIDS and for death by pattern and type of NIDU.Findings During follow‐up, 285 AIDS events and 287 deaths, of which 177 were AIDS‐related, were reported. At baseline, consistent and former NIDU was associated with CD4+ counts of < 200 cells/µl (43% and 46%, respectively) and viral load > 40 000 copies/ml (53% and 55%, respectively). Consistent NIDU reported less HAART use (53%) compared with other NIDU patterns. Stimulant use was associated with CD4+ cell counts of < 200 cells/µl (53%) and lower HAART initiation (63%) compared with other NIDU types. In multivariate analyses, progression to AIDS was significantly higher among consistent (RH = 2.52), inconsistent (RH = 1.63) and former (RH = 1.56) users compared with never users; and for stimulant (RH = 2.04) and polydrug (RH = 1.65) users compared with non‐users. Progression to all‐cause death was higher only among former users (RH = 1.48) compared with never users in multivariate analysis. NIDU behaviors were not associated with progression to AIDS‐related death.Conclusions In this study, pattern and type of NIDU were associated with HIV progression to AIDS and all‐cause mortality. These differences were associated with lower HAART utilization among consistent NIDU and use of stimulants, and poor baseline immunological and virological status among former users.Keywords
This publication has 50 references indexed in Scilit:
- Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.The Journal of Infectious Diseases, 2003
- Impact of Active Drug Use on Antiretroviral Therapy Adherence and Viral Suppression in HIV-infected Drug UsersJournal of General Internal Medicine, 2002
- Adherence to Antiretroviral Therapy and Its Association with Sexual Behavior in a National Sample of Women with Human Immunodeficiency VirusClinical Infectious Diseases, 2002
- Direct Comparison of Time to AIDS and Infectious Disease Death Between HIV Seroconverter Injection Drug Users in Italy and the United States: Results From the ALIVE and ISS StudiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Bacterial Pneumonia in Persons Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1995
- Socially desirable responding and self‐reported HIV infection risk behaviors among intravenous drug usersAddiction, 1993
- Disease Progression and Early Predictors of AIDS in HIV-Seroconverted Injecting Drug Users the Italian Seroconversion StudyAIDS, 1992
- Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.BMJ, 1990
- Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell coculturesAIDS, 1990
- Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expressionClinical Immunology and Immunopathology, 1986